The second edition of a predoctoral programme for physicians enhances different facets of research
Following the success of the first edition of the PhD programme for physicians - PhD4MD, an initiative created by the Centre for Genomic Regulatio...
News from 2016
Dr. de la Rocha receives 2 million euros from the ERC for the study of neural mechanisms
Dr. Jaime de la Rocha, head of Cortical Circuit Dynamics research group at IDIBAPS, will receive €2 million over the next five years to strengthen...
IDIBAPS takes part in a 30 million euros project to develop new HIV vaccines
IDIBAPS takes part in the European HIV Vaccine Alliance (EHVA) to develop and evaluate new preventive and therapeutic vaccines. The European Commi...
A study identifies areas of the genome involved in the response to lithium in bipolar disorder
Researchers from Hospital Clínic, IDIBAPS, University of Barcelona (UB) and Mental Health Research Center (CIBERSAM), associated with Institute o...
IDIBAPS and Fundació Clínic take part in EATRIS and ECRIN, two European Research Infrastructure Consortium
IDIBAPS and Fundació Clínic take part in two of the ERIC (European Research Infrastructure Consortium) consortiums promoted by the European Commiss...
A nutritional combination of saturated fatty acids can induce steatohepatitis
Researchers from the IIBB-CSIC and IDIBAPS have published an article in Oncotarget journal in which they have shown for the first time that diets...
Four researchers at Hospital Clínic and IDIBAPS among the 2015 most cited scientists
Dr. Jordi Bruix, Head of the hepatic Oncology Unit at Hospital Clínic de Barcelona, the Hepatic Oncology IDIBAPS research team, the Barcelona Clin...
A genetic test at the time of diagnosis, useful for predicting treatment response in breast cancer
Researchers at Hospital Clínic and IDIBAPS lead a study in which a genomic test performed at the time of diagnosis in breast cancer is useful to id...
Aelix Therapeutics gets €11.5M for therapeutic HIV vaccine
Aelix Therapeutics, a drug development company created from the HIVACAT project and specialized in the discovery and development of immunotherapies...
The group led by Dr. Josep Dalmau, new CIBERER incorporation
The CIBERER (Networked Biomedical Research Center for Rare Diseases) has incorporated two new research groups, among them the Pathogenesis of auto...